Massachusetts Financial Services CO Aquestive Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $179,288 - $283,918	-54,495 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$4.17 - $6.73 $26,925 - $43,455	-6,457 Reduced 10.59%	54,495 $283,000
Q4 2020 Feb 12, 2021	SELL	$4.65 - $7.79 $2,855 - $4,783	-614 Reduced 1.0%	60,952 $326,000
Q3 2020 Nov 12, 2020	BUY	$4.12 - $9.09 $253,651 - $559,634	61,566 New	61,566 $299,000
Q4 2019 Feb 13, 2020	SELL	$3.06 - $8.78 $898,492 - $2.58 Million	-293,625 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$3.04 - $4.91 $546,069 - $881,973	-179,628 Reduced 37.96%	293,625 $934,000
Q2 2019 Aug 14, 2019	SELL	$3.72 - $6.95 $1,376 - $2,571	-370 Reduced 0.08%	473,253 $1.99 Million
Q1 2019 May 13, 2019	SELL	$5.74 - $8.05 $1,762 - $2,471	-307 Reduced 0.06%	473,623 $3.27 Million
Q4 2018 Feb 08, 2019	BUY	$6.09 - $18.0 $1.04 Million - $3.08 Million	170,984 Added 56.44%	473,930 $2.99 Million
Q3 2018 Oct 25, 2018	BUY	$15.0 - $18.96 $4.54 Million - $5.74 Million	302,946 New	302,946 $5.31 Million

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.